GeoVax Labs, Inc. announced recent key staff appointments and changes. Jeffrey Welch has been appointed to serve as Head, Process Development and Manufacturing Operations (consultant). In this role, Jeff will provide oversight and direction to enhance GeoVax's manufacturing capacity of MVA-related products, a key element in advancing the Company's current and upcoming clinical development programs. Jeff brings over 30 years of experience in biopharmaceutical development and CMC operations, with expertise in manufacturing process development and technical operations related to vaccines and specifically related to MVA.

Erica Raiden has been appointed to serve as Director, Clinical Operations. In this role, Erica will work closely with CRO partners and engage with clinical sites to facilitate advancing clinical trials, ensuring that clinical development programs are aligned with corporate objectives and priorities and proceeding in a timely manner. Erica brings over 25 years of progressive experience in clinical project management, regulatory affairs and scientific research.

The Company also announced that Mark J. Newman, PhD, Chief Scientific Officer, is now serving in a full-time capacity, having previously worked on a part-time basis.